Retraction: SUMOylation of Mouse p53b by SUMO-1 Promotes Its Pro-Apoptotic Function in Ovarian Granulosa Cells (PLoS ONE (2013) 8: 5 (e63680) DOI: 10.1371/journal.pone.0063680);SUMOylation of Mouse p53b by SUMO-1 Promotes Its Pro-Apoptotic Function in Ovarian Granulosa Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Liu, Xiao Ming ^a   Yang, Fei Fei ^a   Yuan, Yi Feng ^a   Zhai, Rui ^a   Huo, Li Jun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; PROTEIN P53; SUMO 1 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DOSE RESPONSE; GENE MUTATION; GRANULOSA CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; OVARY CELL; OVARY FOLLICLE ATRESIA; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; SUMOYLATION; WESTERN BLOTTING;

EID: 84877794514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0248927     Document Type: Erratum

References (54)

1. Hughes FM Jr, Gorospe WC, (1991) Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinology 129: 2415-2422.
2. Gougeon A, (1996) Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 17: 121-155.
3. Jiang JY, Cheung C, Wang Y, Tsang BK, (2003) Regulation of cell death and cell survival gene expression during ovarian follicular development and atresia. Front Biosci 8: 222-237.
4. Kaipia A, Hsueh AJ, (1997) Regulation of ovarian follicle atresia. Annu Rev Physiol 59: 349-363.
5. Perez GI, Robles R, Knudson CM, Flaws JA, Korsmeyer SJ, et al. (1999) Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nature genetics 21: 200-203.
6. Tilly JL, Kowalski KI, Johnson AL, Hsueh AJ, (1991) Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 129: 2799-2801.
7. Hirshfield AN, (1991) Development of follicles in the mammalian ovary. Int Rev Cytol 124: 43-101.
8. Boone DL, Carnegie JA, Rippstein PU, Tsang BK, (1997) Induction of apoptosis in equine chorionic gonadotropin (eCG)-primed rat ovaries by anti-eCG antibody. Biol Reprod 57: 420-427.
9. Crook T, Marston NJ, Sara EA, Vousden KH, (1994) Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79: 817-827.
10. MATSUDA-MINEHATA F, INOUE N, GOTO Y, MANABE N, (2006) The regulation of ovarian granulosa cell death by pro-and anti-apoptotic molecules. Journal of Reproduction and Development 52: 695-705.
11. MATSUDA-MINEHATA F, Maeda A, Cheng Y, Sai T, Gonda H, et al. (2008) Regulation of granulosa cell apoptosis by death ligand-receptor signaling. Animal Science Journal 79: 1-10.
12. Bargonetti J, Manfredi JJ, (2002) Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14: 86-91.
13. Fridman JS, Lowe SW, (2003) Control of apoptosis by p53. Oncogene 22: 9030-9040.
14. Levine AJ, (1997) p53, the cellular gatekeeper review for growth and division. Cell 88: 323-331.
15. Vousden KH, Lu X, (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
16. Kim JM, Yoon YD, Tsang BK, (1999) Involvement of the Fas/Fas ligand system in p53-mediated granulosa cell apoptosis during follicular development and atresia. Endocrinology 140: 2307-2317.
17. Ko LJ, Prives C, (1996) p53: puzzle and paradigm. Genes & development 10: 1054.
18. Ruaro EM, Collavin L, Del Sal G, Haffner R, Oren M, et al. (1997) A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1. Proceedings of the National Academy of Sciences 94: 4675.
19. Asselin E, Xiao CW, Wang YF, Tsang BK, (2000) Mammalian follicular development and atresia: role of apoptosis. Biol Signals Recept 9: 87-95.
20. Jiang JY, Cheung CK, Wang Y, Tsang BK, (2003) Regulation of cell death and cell survival gene expression during ovarian follicular development and atresia. Front Biosci 8: d222-237.
21. Han KA, Kulesz-Martin MF, (1992) Alternatively spliced p53 RNA in transformed and normal cells of different tissue types. Nucleic acids research 20: 1979-1981.
22. Bode AM, Dong Z, (2004) Targeting signal transduction pathways by chemopreventive agents. Mutat Res 555: 33-51.
23. Toledo F, Wahl GM, (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6: 909-923.
24. Olsson A, Manzl C, Strasser A, Villunger A, (2007) How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death & Differentiation 14: 1561-1575.
25. Melchior F, (2000) SUMO-nonclassical ubiquitin. Annual review of cell and developmental biology 16: 591-626.
26. Meluh PB, Koshland D, (1995) Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Molecular biology of the cell 6: 793.
27. Müller S, Hoege C, Pyrowolakis G, Jentsch S, (2001) SUMO, ubiquitin's mysterious cousin. Nature reviews Molecular cell biology 2: 202.
28. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, et al. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. The EMBO journal 18: 6462-6471.
29. Kwek SS, Derry J, Tyner AL, Shen Z, Gudkov AV, (2001) Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 20: 2587-2599.
30. Rodriguez MS, Desterro JMP, Lain S, Midgley CA, Lane DP, et al. (1999) SUMO-1 modification activates the transcriptional response of p53. Science's STKE 18: 6455.
31. Schmidt D, Muller S, (2002) Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci U S A 99: 2872-2877.
32. Carter S, Vousden KH, (2008) p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53. Cell Cycle 7: 2519-2528.
33. Müller S, Berger M, Lehembre F, Seeler JS, Haupt Y, et al. (2000) c-Jun and p53 activity is modulated by SUMO-1 modification. Journal of Biological Chemistry 275: 13321-13329.
34. Mauri F, McNamee LM, Lunardi A, Chiacchiera F, Del Sal G, et al. (2008) Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions. Journal of Biological Chemistry 283: 20848-20856.
35. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, et al. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18: 6462-6471.
36. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, et al. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J 18: 6455-6461.
37. Kinzler KW, Vogelstein B, (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761-763.
38. Hofseth LJ, Hussain SP, Harris CC, (2004) p53: 25 years after its discovery. Trends Pharmacol Sci 25: 177-181.
39. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
40. Perry JJ, Tainer JA, Boddy MN, (2008) A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem Sci 33: 201-208.
41. Weger S, Hammer E, Heilbronn R, (2005) Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS letters 579: 5007-5012.
42. Yang X, Li H, Zhou Z, Wang WH, Deng A, et al. (2009) Plk1-mediated phosphorylation of Topors regulates p53 stability. J Biol Chem 284: 18588-18592.
43. Stehmeier P, Muller S, (2009) Regulation of p53 family members by the ubiquitin-like SUMO system. DNA repair 8: 491-498.
44. Bakkers J, Camacho-Carvajal M, Nowak M, Kramer C, Danger B, et al. (2005) Report Destabilization ofΔ Np63α by Nedd4-Mediated Ubiquitination and Ubc9-Mediated Sumoylation, and Its Implications on Dorsoventral Patterning of the Zebrafish Embryo. Cell Cycle 4: 790-800.
45. Ghioni P, D'Alessandra Y, Mansueto G, Jaffray E, Hay RT, et al. (2005) The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation. Cell Cycle 4: 183-190.
46. Ulrich HD, (2005) Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends in cell biology 15: 525-532.
47. Hu W (2009) The role of p53 gene family in reproduction. Cold Spring Harbor perspectives in biology 1.
48. Hu W, Feng Z, Teresky AK, Levine AJ, (2007) p53 regulates maternal reproduction through LIF. Nature 450: 721-724.
49. Meikrantz W, Schlegel R, (1995) Apoptosis and the cell cycle. Journal of cellular biochemistry 58: 160-174.
50. Hussein MR, (2005) Apoptosis in the ovary: molecular mechanisms. Human reproduction update 11: 162-178.
51. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin H, et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799.
52. Tilly J, Tilly K, Kenton M, Johnson A, (1995) Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels. Endocrinology 136: 232-241.
53. Cory S, Adams JM, (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nature Reviews Cancer 2: 647-656.
54. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, et al. (2003) p53 has a direct apoptogenic role at the mitochondria. Molecular cell 11: 577-590.